Models of the Aging Brain Structure and Individual Decline

Purpose of review The aim of this study was to discuss the contribution of neuroimaging studies to our understanding of Alzheimer's disease. We now have the capability of measuring both tau and beta-amyloid (A&bgr;) proteins in the brain, which together with more traditional neuroimaging modalities, has led the field to focus on using neuroimaging to better characterize disease mechanisms underlying Alzheimer's disease. Recent findings Studies have utilized tau and A&bgr; PET, as well as [18F]fluorodeoxyglucose PET, and structural and functional MRI, to investigate the following topics: phenotypic variability in Alzheimer's disease , including how neuroimaging findings are related to clinical phenotype and age; multimodality analyses to investigate the relationships between different neuroimaging modalities and what that teaches us about disease mechanisms; disease staging by assessing neuroimaging changes in the very earliest phases of the disease in cognitively normal individuals and individuals carrying an autosomal dominant Alzheimer's disease mutation; and influence of other comorbidities and proteins to the disease process. Summary The findings shed light on the role of tau and A&bgr;, as well as age and other comorbidities, in the neurodegenerative process in Alzheimer's disease. This knowledge will be crucial in the development of better disease biomarkers and targeted therapeutic approaches.

[1]  M. Jorge Cardoso,et al.  [Accepted Manuscript] Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study. , 2017 .

[2]  W. M. van der Flier,et al.  Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline , 2017, Alzheimer's Research & Therapy.

[3]  David T. Jones,et al.  [18F]AV‐1451 clustering of entorhinal and cortical uptake in Alzheimer's disease , 2018, Annals of neurology.

[4]  Xin Xu,et al.  Influence of cerebrovascular disease on brain networks in prodromal and clinical Alzheimer’s disease , 2017, Brain : a journal of neurology.

[5]  J. Phillips,et al.  Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease , 2018, Human brain mapping.

[6]  J. Trojanowski,et al.  Heterogeneity of neuroanatomical patterns in prodromal Alzheimer’s disease: links to cognition, progression and biomarkers , 2016, Brain : a journal of neurology.

[7]  Keith A. Johnson,et al.  Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals , 2017, The Journal of Neuroscience.

[8]  Keith A. Johnson,et al.  Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex , 2017, JAMA neurology.

[9]  Michael Schöll,et al.  Amyloid and tau PET demonstrate region-specific associations in normal older people , 2017, NeuroImage.

[10]  N. Tustison,et al.  Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake , 2018, Neurobiology of Aging.

[11]  M. Jorge Cardoso,et al.  Patterns of progressive atrophy vary with age in Alzheimer's disease patients , 2018, Neurobiology of Aging.

[12]  J. Phillips,et al.  18F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease , 2017, The Journal of Nuclear Medicine.

[13]  Yi Su,et al.  Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia , 2017, Alzheimer disease and associated disorders.

[14]  R. Petersen,et al.  Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.

[15]  Keith A. Johnson,et al.  Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease , 2017, JAMA neurology.

[16]  G. Chételat,et al.  Distinct influence of specific versus global connectivity on the different Alzheimer’s disease biomarkers , 2017, Brain : a journal of neurology.

[17]  Christopher G Schwarz,et al.  Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. , 2018, Brain : a journal of neurology.

[18]  M. Mintun,et al.  Association between tau deposition and antecedent amyloid-&bgr; accumulation rates in normal and early symptomatic individuals , 2017, Brain : a journal of neurology.

[19]  M. Mintun,et al.  Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition , 2017, Brain : a journal of neurology.

[20]  Keith A. Johnson,et al.  Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease , 2018, JAMA neurology.

[21]  R. Bateman,et al.  Tau Positron Emission Tomography in Autosomal Dominant Alzheimer Disease: Small Windows, Big Picture. , 2018, JAMA neurology.

[22]  Hanna Cho,et al.  Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease , 2017, Neurobiology of Aging.

[23]  Gereon R Fink,et al.  NETWORKS OF TAU DISTRIBUTION IN ALZHEIMER’S DISEASE , 2017, Alzheimer's & Dementia.

[24]  Y. Noh,et al.  Functional Connectivity of the Hippocampus in Early- and vs. Late-Onset Alzheimer's Disease , 2017, Journal of clinical neurology.

[25]  O. Hansson,et al.  Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks , 2017, Front. Neurosci..

[26]  Shannon L. Risacher,et al.  Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline , 2017, Neurology.

[27]  C. Jack,et al.  Rates of hippocampal atrophy and post-mortem TDP-43 in Alzheimer’s disease: a longitudinal retrospective study , 2017, The Lancet Neurology.

[28]  M. Filippi,et al.  Brain network connectivity differs in early-onset neurodegenerative dementia , 2017, Neurology.

[29]  Luca Passamonti,et al.  Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy , 2018, Brain : a journal of neurology.

[30]  Peter R. Martin,et al.  Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.

[31]  Magda Tsolaki,et al.  Heterogeneous patterns of brain atrophy in Alzheimer's disease , 2018, Neurobiology of Aging.

[32]  Daniel R. Schonhaut,et al.  Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease , 2017, NeuroImage: Clinical.

[33]  C. Jack,et al.  Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study , 2017, The Lancet Neurology.

[34]  Prashanthi Vemuri,et al.  Age, vascular health, and Alzheimer disease biomarkers in an elderly sample , 2017, Annals of neurology.

[35]  P. Yushkevich,et al.  Early Tau Burden Correlates with Higher Rate of Atrophy in Transentorhinal Cortex. , 2018, Journal of Alzheimer's disease : JAD.

[36]  Gereon R. Fink,et al.  Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease , 2016, Annals of clinical and translational neurology.

[37]  James B. Rowe,et al.  PET Tau and Amyloid-β Burden in Mild Alzheimer’s Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers , 2017, Journal of Alzheimer's disease : JAD.

[38]  Norbert Schuff,et al.  Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns , 2017, Scientific Reports.

[39]  Jorge Sepulcre,et al.  Fluorodeoxyglucose metabolism associated with tau‐amyloid interaction predicts memory decline , 2017, Annals of neurology.

[40]  Daniel C Alexander,et al.  Data-driven models of dominantly-inherited Alzheimer’s disease progression , 2018, bioRxiv.

[41]  David T. Jones,et al.  Tau-negative amnestic dementia masquerading as Alzheimer disease dementia , 2018, Neurology.

[42]  Rik Ossenkoppele,et al.  Distinct 18F‐AV‐1451 tau PET retention patterns in early‐ and late‐onset Alzheimer's disease , 2017, Brain : a journal of neurology.

[43]  Andrew J. Saykin,et al.  Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study , 2018, The Lancet Neurology.

[44]  Christopher G Schwarz,et al.  Longitudinal tau PET in ageing and Alzheimer’s disease , 2018, Brain : a journal of neurology.

[45]  Gereon R Fink,et al.  In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.

[46]  Daniel R. Schonhaut,et al.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. , 2016, Brain : a journal of neurology.

[47]  M. Jorge Cardoso,et al.  White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy , 2017, Hippocampus.

[48]  A. Brickman,et al.  The effect of white matter hyperintensities on cognition is mediated by cortical atrophy , 2018, Neurobiology of Aging.

[49]  Clifford R. Jack,et al.  Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum , 2017, Cortex.

[50]  Clifford R. Jack,et al.  Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease , 2018, Alzheimer's & Dementia.